Sernova (XTER:PSH) ROE % Adjusted to Book Value : -14.40% (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sernova ROE % Adjusted to Book Value?

Sernova's ROE % for the quarter that ended in Jan. 2024 was -476.75%. Sernova's PB Ratio for the quarter that ended in Jan. 2024 was 33.11. Sernova's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 was -14.40%.

Sernova ROE % Adjusted to Book Value Historical Data

The historical data trend for Sernova's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova ROE % Adjusted to Book Value Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.41

-17.03

-10.16

Sernova Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.67	-18.99	-17.67	-20.49	-14.40

Competitive Comparison of Sernova's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Sernova's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sernova's ROE % Adjusted to Book Value falls into.

Sernova ROE % Adjusted to Book Value Calculation

Sernova's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-129.73%	/	12.77
	=	-10.16%

Sernova's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-476.75%	/	33.11
	=	-14.40%

Sernova ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sernova's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (XTER:PSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (XTER:PSH) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.